Management of dyslipidemia in HIV-infected patients | Zendy

Mary C. Sugden | Zendy; Mark J. Holness | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of dyslipidemia in HIV-infected patients

Author(s) -

Mary C. Sugden,

Mark J. Holness

Publication year - 2011

Publication title -

clinical lipidology

Language(s) - English

Resource type - Journals

eISSN - 1758-4299

pISSN - 1758-4302

DOI - 10.2217/clp.11.25

Subject(s) - dyslipidemia , antiretroviral therapy , medicine , human immunodeficiency virus (hiv) , population , intensive care medicine , disease , coronary heart disease , immunology , viral load , environmental health

Antiretroviral therapy has dramatically increased survival for HIV-infected individuals. As this population lives longer, coronary heart disease has become an important comorbid condition. Dyslipidemia in HIV-infected individuals is a complex condition, with multiple contributing factors including the HIV virus itself, individual genetic characteristics and antiretroviral therapy-induced metabolic changes. Effective management of dyslipidemia in this population is essential to reduce cardiovascular risk but presents multiple challenges due to interactions between antiretroviral therapy agents and lipid-lowering medications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research